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Post-translational modiﬁcations are necessary for collagen precursor molecules (procolla-
gens) to acquire ﬁnal shape and function. However, the mechanism and contribution of
collagen modiﬁcations that occur outside the endoplasmic reticulum and Golgi are not
understood. We discovered that VIPAR, with its partner proteins, regulate sorting of lysyl
hydroxylase 3 (LH3, also known as PLOD3) into newly identiﬁed post-Golgi collagen IV
carriers and that VIPAR-dependent sorting is essential for modiﬁcation of lysines in multiple
collagen types. Identiﬁcation of structural and functional collagen abnormalities in cells and
tissues from patients and murine models of the autosomal recessive multisystem disorder
Arthrogryposis, Renal dysfunction and Cholestasis syndrome caused by VIPAR and VPS33B
deﬁciencies conﬁrmed our ﬁndings. Thus, regulation of post-Golgi LH3 trafﬁcking is essential
for collagen homeostasis and for the development and function of multiple organs and
tissues.
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n vertebrates, procollagen-lysine hydroxylation is catalysed by
three lysyl hydroxylase isoenzymes (LH1–3), encoded by
Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase (PLOD1-3)
genes1. LH3/PLOD3 is the only isoenzyme that also generates
hydroxylysine-linked carbohydrates because of its galactosyl- and
glucosyl galactosyl-transferase (GT and GGT) activities, critical
for procollagen intermolecular crosslinking and stabilization of
ﬁbrils into the supramolecular collagen structure2–4. Deﬁciency of
LH3 affects assembly and secretion of multiple collagen types and
leads to abnormal basement membrane formation5–8. All LH
enzymes are thought to exert their function in the endoplasmic
reticulum (ER); however, LH3 is also found in the extracellular
space, both in soluble form and anchored to the external side of
the plasma membrane9–11. While the earlier collagen
modiﬁcation steps have been extensively studied12–16, the
regulatory mechanism and contribution of LH3 modiﬁcations
to collagen homeostasis outside ER and Golgi are not well
understood.
We ﬁnd that LH3 interacts with a trafﬁcking protein, VIPAR.
Deﬁciencies of VIPAR and its partner VPS33B cause arthro-
gryposis, renal dysfunction and cholestasis syndrome (ARC), a
multisystem disorder with characteristic developmental and
functional defects of the musculoskeletal system, kidneys, liver,
skin and platelets that shows some overlap with a clinical
phenotype seen in a patient with inherited LH3 deﬁciency17–21.
The LH3–VIPAR interaction, together with the engagement of
ﬁrst RAB10 and then RAB25, appears to be essential for LH3
trafﬁcking and delivery to newly identiﬁed Collagen IV Carriers
(CIVC) in inner medullary collecting duct cells (mIMCD3). We
found that VPS33B and VIPAR deﬁciencies result in a reduction
of LH3-dependent post-translational modiﬁcation of collagen IV
in these cells accompanied by an abnormal deposition of the
extracellular matrix (ECM) and disruption of cell polarity in three-
dimensional (3D) cyst models of VPS33B, VIPAR, and LH3 kd cells.
LH3-speciﬁc collagen modiﬁcation levels are reduced in ARC
patients’ urine, as well as in collagen I from cultured skin
ﬁbroblasts. In addition, structural defects in collagen I are found
in tail tendons from VPS33B- and VIPAR-deﬁcient mice. Taken
together, these ﬁndings establish a role for VPS33B/VIPAR in the
intracellular trafﬁcking of LH3 and collagen homeostasis.
Results
LH3 is a novel VIPAR N-terminal interactor. We identiﬁed
LH1 and LH3 isoenzymes as potential interactors of the coex-
pressed His6-cMyc4-tagged VPS33B and His6-StrepII3-tagged
VIPAR in human embryonic kidney 293 (HEK293) cells using a
pull-down assay and analysis of the puriﬁed sample by electro-
spray ionization liquid chromatography tandem mass spectro-
metry (LC-MS/MS; Supplementary Fig. 1a,d). While the LH1
interaction was not conﬁrmed in vitro, the interaction with LH3
was further supported by co-immunoprecipitation of transiently
expressed VPS33B and VIPAR with endogenous LH3 and colo-
calization of the endogenous proteins (Fig. 1a–e).
VPS33B and VIPAR are homologous to yeast Vps33p and
Vps16p—core constituents of the multiprotein HOPS (HOmo-
typic fusion and vacuole Protein Sorting) and CORVET (class C
core vacuole/endosome tethering) tethering complexes22.
Metazoans have two homologues of each Vps33p and Vps16p,
and recent evidence suggested that only VPS33A and VPS16
homologues are members of the conventional mammalian HOPS
and CORVET complexes, while functions of VIPAR and VPS33B
remain unknown23–26. Our in silico analysis showed that human
VPS33B (UniProt Q9H267) is structurally similar to homologous
VPS33A, whereas VIPAR (UniProt Q9H9C1) is a 57-kDa protein
characterized by a long disordered region ofB130 amino acids at
its N terminus, followed by a globular alpha-solenoid divergent in
sequence but structurally related to the C terminus of VPS16
(Supplementary Fig. 2a). Further homology modelling using the
human VPS33A-VPS16 and fungal VPS33–VPS16 crystal
structures23,24 as references agreed with this predicted domain
organization of VIPAR (Supplementary Fig. 2b), suggesting an
extended interaction platform deﬁned by the concave side of
VIPAR alpha-solenoid domain embracing the globular VPS33B.
This interface is structurally similar to that observed in the
VPS33A-VPS16 complex, but is characterized by numerous
unique complementary electrostatic and hydrophobic contacts
(Supplementary Fig. 2c). Analytical gel ﬁltration analysis showed
that VPS33B and VIPAR co-elute in a single peak
(Supplementary Fig. 1b), supporting the predicted strong
macromolecular interactions between the two proteins. This
observation is further supported by the largely improved
recombinant expression yields for VPS33B and VIPAR when
the two proteins are coexpressed in HEK293 cells compared with
production of single proteins (Supplementary Fig. 1c).
Pull-down experiments using recombinant short fragments of
human VIPAR corroborated this structural organization, indicat-
ing that the ﬂexible N-terminal region of the protein is
dispensable for VPS33B interaction (Fig. 1b,c). Using the same
pull-down strategy, we established that the ﬂexible N terminus of
VIPAR is necessary and sufﬁcient for LH3 interaction (Fig. 1b,c).
The amino-acid sequence of VIPAR N terminus is not
conserved in VPS16. Comparative bioinformatics predictions
suggested that the presence of transmembrane segments in this
region is unlikely and, in parallel, recombinant VIPAR and its
fragments behaved as fully soluble cytoplasmic proteins during
extraction and puriﬁcation. Therefore, as previous studies
suggested LH3 to be a membrane-associated (but not mem-
brane-crossing) protein facing the organellar lumen1,9,10, we
concluded that the VIPAR–LH3 interaction requires an
intermediate transmembrane mediator that is yet to be identiﬁed.
VIPAR–LH3 interaction and its signiﬁcance for LH3 secretion.
We then examined the intracellular localization of LH3–VIPAR
interaction and whether VIPAR and VPS33B deﬁciencies affected
LH3 distribution. First, we found that in human skin ﬁbroblasts
there was a higher level of colocalization of endogenous LH3 with
the trans-Golgi network (TGN) protein TGN46 staining than with
the ER markers PDI and Calreticulin (Supplementary Fig. 3). We
then identiﬁed colocalization of both endogenous LH3 and VIPAR
with TGN46 and the TGN-speciﬁc clathrin adaptor AP1 in HeLa
cells (Fig. 1d,e). LH3-mCherry partially colocalized with Golgin97
TGN marker (Supplementary Fig. 4a) in murine inner medullary
collecting duct (mIMCD3) cell line previously used to model
apical–basolateral polarity defects of ARC syndrome20.
As LH3 is normally secreted into the ECM and found in
circulation10,11, we tested whether VPS33B and VIPAR are
necessary for extracellular secretion of LH3 by measuring intra-
and extracellular LH3 GGT activity in mIMCD3 cell lines: wild-
type (wt) and stable knockdown (kd) clones including control
short hairpin RNA (shRNA), VIPAR shRNA and VPS33B
shRNA (Supplementary Fig. 5a,b). A small increase in the
extracellular GGT activity of LH3 was found in both VIPAR
shRNA and VPS33B shRNA cells compared with both wt and
control shRNA without signiﬁcant changes in the intracellular
measurements, suggesting that the extracellular secretion of LH3
was not impaired by VIPAR or VPS33B deﬁciencies.
VPS33B-VIPAR mediate LH3 delivery to collagen IV carriers.
Consistent with collagen IV being the major kidney constituent
protein modiﬁed by LH3, in control shRNA cells the majority
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(B90%) of LH3-mCherry-positive puncta colocalized with intra-
cellular collagen IV, while a small proportion of LH3
colocalized with the late endosome and lysosome marker CD63
(Figs 2a and 3a). The punctate collagen IV staining was unchanged
after LH3 transfection (Fig. 2a,b). Although at the light micro-
scopic level some of the LH3-collagen IV puncta appeared to
colocalize with the ER marker calreticulin (Supplementary Fig. 4b),
correlative light and electron microscopy (CLEM) images identiﬁed
LH3 in discrete cytoplasmic membrane-bound structures located
near but distinct from the ER (Fig. 2c).
The LH3-mCherry colocalization with intracellular collagen IV
was lost in VIPAR shRNA cells (Fig. 2a) where an increase
in LH3 colocalization with TGN38 and CD63 was detected
(Figs 2a and 3a). LH3-collagen IV colocalization was rescued by
re-introducing CFP-VIPAR and YFP-VPS33B (Fig. 2a). Pioneering
studies of procollagen transport have elucidated ER to Golgi and
intra-Golgi trafﬁcking steps12–16,27–29; however, the post-Golgi
collagen IV compartment has not been characterized. Therefore,
we performed CLEM with 3D reconstruction to describe the sites of
LH3 and collagen IV colocalization. Approximately 20 cytoplasmic
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Figure 1 | LH3 interacts with the N terminus of VIPAR at the TGN. (a) Co-immunoprecipitation of endogenous LH3 with myc-VIPAR in HEK293 cells.
HEK293 cells were transfected with HA-VPS33B and/or myc-tagged VIPAR. After anti-HA (left) or anti-myc (right) immunoprecipitation, samples were
immunoblotted using anti-LH3, anti-HA or anti-myc antibodies. Experiment was repeated three times. (b) Schematic representation of the fragments of
VIPAR used to investigate its interactions with VPS33B and LH3: full-length (FL), the ﬂexible N terminus of VIPAR (N), two C-terminal constructs (C and
Cþ ) including the putative alpha-solenoid region (oval cartoon), with two different starting points based on secondary structure predictions. (c) HEK293
cells were co-transfected with myc-tagged VIPAR constructs represented in b and HA-VPS33B. Immunoprecipitation was performed with anti-myc
antibody. Immunoprecipitates and inputs were blotted with anti-LH3, anti-HA or anti-myc antibodies. Experiment repeated three times. In a,c
representative blots are shown. Uncropped western blots are shown in Supplementary Fig. 11. (d) Colocalization analysis of endogenous LH3, VIPAR and
TGN46 in HeLa cells. (VIPAR/LH3, n¼ 9; LH3/TGN46, n¼ 51; VIPAR/TGN46, n¼ 22 of pooled data set of two to three independent experiments).
(e) Colocalization of endogenous LH3 with endogenous VIPAR and AP1 (LH3/VIPAR/AP1, n¼ 7 of pooled data set of two independent experiments).
Colocalization for d,e was measured by the Pearson’s coefﬁcient. Error bars represent s.d. Figures show representative data and images. Scale bars, 10mm.
HeLa rather than mIMCD3 cells were used because of anti-LH3 and anti-VIPAR unsuitability for immunostaining of mouse cells.
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membrane-bound CIVC per cell were identiﬁed in wt mIMCD3
cells. Most CIVCs were B400nm in their largest diameter
(range 200–900 nm), and were consistently circular in cross-section
(Fig. 2c,d and Supplementary Fig. 9b). The content of individual
CIVCs varied slightly but generally was marginally more
electron-dense than the cytoplasm, containing one or more intact
small vesicle(s), one or more small electron-dense non-membranous
granule(s), and occasionally a small membranous whorl. The
presence of collagen IV in LH3 containing CIVCs was further
conﬁrmed by CLEM of LH3-mCherry coupled to
immunoperoxidase staining for collagen IV. The oxidation of DAB
delineated collagen IV-positive dark areas (detectable by EM) that
overlapped with LH3 positive puncta (detectable by light microscopy)
(Supplementary Fig. 9). DAB-positive staining for collagen IV but
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Figure 2 | VIPAR mediates post-Golgi LH3 trafﬁcking to collagen IV carriers. (a) Control shRNA (top row) or VIPAR shRNA (middle row) mIMCD3 cells
were transfected with LH3-mCherry and GFP-TGN38 and immunostained for endogenous collagen IV. CFP-VIPAR and YFP-VPS33B were re-introduced in
VIPAR shRNA cells, transfected with LH3-mCherry and immunostained for endogenous collagen IV (bottom row). Merge panels are shown separately
between LH3-mCherry (red) with GFP-TGN38 (green), and LH3-mCherry (red) with collagen IV (blue). CFP and YFP emission channels are shown
superimposed because of the complete overlap. Controls were performed to exclude the crosstalk between the two channels. Colocalization between
collagen IV and LH3-mCherry was measured by the Pearson’s coefﬁcient. Error bars represent s.d. Figures show representative images. (Upper graph:
Control shRNA, n¼ 6; VIPAR shRNA, n¼9 of pooled data set of two independent experiments; P¼0.0388 using Mann–Whitney, two-tailed.). (Lower
graph: Control shRNA, n¼ 13; VIPAR shRNA, n¼ 37; VIPAR shRNA rescue, n¼9 of pooled data set of three independent experiments; Po0.0001 and
P¼0,0261 using Mann–Whitney, two-tailed). Scale bars, 10 mm. (b) Confocal ﬂuorescence photomicrograph of control shRNA mIMCD3 cells without
other transfections, immunostained for endogenous collagen IV. (c) CLEM of control shRNA cells transfected with LH3-mCherry. Left image: overlay of the
maximum intensity ﬂuorescence image and electron micrograph of a single ultrathin section. Insert shows the composite of the ﬂuorescence and DIC
image of the same cell. Scale bar, 20mm. Right image: higher-magniﬁcation electron micrograph of a region of interest boxed in left image showing
characteristic LH3-positive structures consistent with the light microscopy images of CIVCs. Gradient transparency was applied to ﬂuorescent image to
show the details of the ultrastructure. Scale bar, 1mm. Arrow indicates CIVC shown in the insert (from another section in the series; scale bar, 200nm). A
serial section of the insert is shown in Supplementary Fig. 9b. Images are representative of n¼ 70 CIVCs from ﬁve different cells pooled from two independent
experiments. (d) Histogram demonstrating the size ranges of the largest diameter of each individual reconstructed CIVC. *Pr0.05, ****Pr0.0001.
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not LH3-mCherry, was visible in structures resembling the ER
(Supplementary Fig. 9).
None of the LH3-positive puncta were found to localize to
these characteristic CIVCs in the VIPAR kd cells where LH3 was
found exclusively in larger membrane-bound structures of
irregular shape that contained highly electron-dense material
resembling degraded membranes, consistent with the CD63-
positive endosomes containing LH3 identiﬁed with light micro-
scopy (Fig. 3b and Supplementary Fig. 9c). Taken together, the
data above suggest that VIPAR and VPS33B deﬁciencies result in
a block of LH3 delivery to CIVCs and an increase in its delivery to
late endosomes for degradation and/or secretion.
RAB10 and RAB25 are involved in post-Golgi LH3 sorting.
RAB GTPases cycle between active GTP-bound and inactive
GDP-bound states and regulate speciﬁc steps in intracellular
trafﬁcking by recruiting ‘effector’ molecules30. Since previous data
suggested that VPS33B and VIPAR in complex regulate
apical–basolateral polarity and may act as an effector for RAB11A
associated with recycling endosomes20, we examined whether
RAB11A, RAB25 and RAB10 proteins are required for LH3 delivery
to CIVCs because of their involvement in recycling endosome
function and in apical–basolateral polarity regulation31–33.
Low level of colocalization was found between RAB11A and
LH3-mCherry, while overexpression of RAB11A-dominant-
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Figure 3 | VIPAR deﬁciency enhances LH3 delivery to CD63-positive structures. (a) Confocal ﬂuorescence photomicrographs of control and VIPAR
shRNA-treated mIMCD3 cells, co-transfected with LH3-mCherry and GFP-CD63 and immunostained for endogenous collagen IV. Colocalization between
LH3-mCherry and GFP-CD63 was measured by the Pearson’s coefﬁcient. Error bars represent s.d. Figures show representative images (Control shRNA,
n¼ 16; VIPAR shRNA, n¼ 12 of pooled data set of three independent experiments; P¼0.0173 using Mann–Whitney, two-tailed). Scale bars, 10mm.
(b) CLEM of VIPAR shRNA mIMCD3 cells transfected with LH3-mCherry. Left image: overlay of the maximum intensity ﬂuorescence image and the
electron micrograph of a single transmitted electron microscope (TEM) section. Insert shows the composite of the ﬂuorescence and DIC image of the same
cell. Scale bar, 20mm. Right image: higher magniﬁcation of the region of interest boxed in the left image showing characteristic LH3-positive structures in
VIPAR kd cells consistent with the light microscopy images of CD63-positive structures. Scale bar, 1 mm. Gradient transparency was applied to ﬂuorescence
image to show the details of the ultrastructure. Arrow indicates LH3-positive structure with internal dense material shown on the insert (from another
section in the series; scale bar, 500nm). A serial section of the insert is shown in Supplementary Fig. 9c. Images are representative of ﬁve different cells
pooled from two independent experiments. Scale bar for serial sections, 500nm. *Pr0.05.
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negative mutant did not signiﬁcantly affect LH3-collagen
colocalization (Supplementary Fig. 6a). On the contrary,
both RAB10 and RAB25 were found to be present in puncta
positive for overexpressed CFP-VIPAR and LH3-mCherry
(Supplementary Fig. 6b,c). Furthermore, VPS33B alone and when
coexpressed with VIPAR co-immunoprecipitated with both
RAB25 and RAB10 (Fig. 4a), suggesting that the potential
RAB10 and RAB25 involvement in LH3 trafﬁcking is mediated by
VPS33B.
Puncta positive for LH3-mCherry colocalized with RAB10 and
RAB25 in wt and control shRNA, while in VIPAR shRNA cells
(which also had reduced VPS33B expression; Supplementary
Fig. 5b) LH3-mCherry colocalization with RAB10 and RAB25
was reduced (RAB10; Fig. 4b) or lost (RAB25; Fig. 4c). Neither
RAB10 nor RAB25-positive puncta that colocalized with LH3-
mCherry also colocalized with collagen IV, suggesting that these
interactions may occur before LH3 delivery to CIVCs. RAB10 and
VIPAR-positive puncta colocalized with the Golgin97 TGN
marker (Supplementary Fig. 6b). Overexpression of RAB10-
dominant-negative mutant RAB10 (T23N) prevented LH3-
mCherry colocalization with collagen IV and RAB25 (Fig. 5a),
while overexpression of RAB25-dominant-negative mutant
(T26N) resulted in a loss of LH3-mCherry colocalization with
collagen IV but not with GFP-RAB10 (Fig. 5b), placing RAB10
function proximal to RAB25. Taken together, these data provide
evidence for the sequential involvement of RAB10 and RAB25 in
LH3 transport to CIVCs (Supplementary Fig. 7).
Molecular and cellular defects in the kd mIMCD3 cells. We
questioned whether defective sorting of LH3 to CIVCs in VIPAR
shRNA and VPS33B shRNA cells affects collagen IV modiﬁcation
and whether all three kd’s result in similar morphological chan-
ges. Our mIMCD3 cell culture experiments suggested that higher
than 75% kd of LH3 resulted in cell death; thus, we accepted a
lower kd level for LH3 shRNA than for VIPAR shRNA and
VPS33B shRNA (Supplementary Fig. 5b). LH3-deﬁcient cells and
tissues are known to accumulate abnormally modiﬁed collagen
and are unable to correctly form basement membranes, resulting
in severe developmental defects and embryonic lethality in a
complete LH3 knockout (ko) mouse5,7,8. Similarly to LH3 kd
cells, an increase in the intracellular collagen IV was observed also
in VPS33B and VIPAR kd (Fig. 6a,b). A corresponding decrease
in E-cadherin levels was observed in LH3 kd cells as previously
described in VPS33B and VIPAR kd20 (Fig. 6a,c); in addition, in
3D culture all three kd mIMCD3 cell lines were unable to form
spheres with the well-deﬁned lumen and displayed abnormal
deposits of ECM (Fig. 6c,d). Using mass spectrometry we
detected a similar reduction in the levels of LH3-mediated post-
translational modiﬁcations in collagen IV in VPS33B, VIPAR and
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Figure 4 | Interaction of RAB10 and RAB25 with VPS33B–VIPAR mediates their colocalization with LH3. (a) HEK293 cells were transiently transfected
with HA-tagged VPS33B, myc-tagged VIPAR, GFP-RAB10 or GFP-RAB10(T23N) (top panel), GFP-RAB25 or GFP-RAB25(T26N) (bottom panel). After anti-
HA immunoprecipitation, samples were separated by SDS–PAGE and immunoblotted using anti-GFP, anti-HA or anti-myc antibodies. Experiment was
repeated two times. Representative blots are shown. Uncropped western blots are shown in Supplementary Fig. 12. (b) Confocal ﬂuorescence
photomicrographs of control shRNA and VIPAR shRNA mIMCD3 cells, co-transfected with LH3-mCherry and GFP-RAB10 and immunostained for
Golgin97. Colocalization between LH3-mCherry and GFP-RAB10 was measured by the Pearson’s coefﬁcient (Control shRNA, n¼ 10; VIPAR shRNA, n¼ 11
of pooled data set of two independent experiments; P¼0.0041 using Mann–Whitney, two-tailed). (c) Confocal ﬂuorescence photomicrographs of control
and VIPAR shRNA cells, co-transfected with LH3-mCherry and GFP-RAB25 and immunostained for Golgin97. Colocalization between LH3-mCherry and
GFP-RAB25 was measured by the Pearson’s coefﬁcient (Control shRNA, n¼ 10; VIPAR shRNA, n¼ 10 of pooled data set of two independent experiments;
P¼0.002 using Mann–Whitney, two-tailed). In b,c error bars represent s.d. Figures show representative images. Scale bars, 10mm. **Pr0.01.
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LH3 kd mIMCD3 cells, conﬁrming that correct LH3 localization
in CIVCs is necessary for collagen modiﬁcation (Fig. 6e and
Supplementary Table 1).
To study the effect of VPS33B, VIPAR and LH3 deﬁciencies on
gene regulation, we used RNA expression arrays and subsequent
in silico analysis (Fig. 6f, Fig. 7 and Supplementary Fig. 10). After
identiﬁcation of differentially expressed genes34, we used the
online software DAVID to determine Gene Ontology (GO)
annotations that were over-represented among the list of
differentially expressed genes35. Similar results were obtained
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across the kd cells, with several enriched GO terms being related
to cell–cell adhesion (Supplementary Table 2). Furthermore, a
strong correlation between gene expression changes across the
kd’s was found when the similarity of the transcriptomes was
analysed (Fig. 7). Lists of the top 100 differentially expressed
genes were compiled for each kd cell line and a strong statistically
signiﬁcant overlap was observed, with 50% of the genes in each
list differentially expressed in all three kd cell lines (Fig. 6f). Gene
Figure 5 | RAB10 and RAB25 are sequentially involved in post-Golgi LH3 trafﬁcking. (a) Confocal ﬂuorescence photomicrographs of control shRNA
mIMCD3 cells co-transfected with LH3-mCherry and GFP-RAB10 or its dominant-negative form GFP-RAB10(T23N) and immunostained for collagen IV
(top rows) or RAB25 (bottom row). (upper graph: þ RAB10, n¼ 11; þRAB10(T23N), n¼ 12 of pooled data set of two independent experiments;
P¼0.0002 using Mann–Whitney, two-tailed). (Lower graph: þ RAB10(T23N), n¼ 8 of pooled data set of two independent experiments.) (b) Confocal
ﬂuorescence photomicrographs of mIMCD3 cells co-transfected with LH3-mCherry and GFP-RAB25 or its dominant-negative form GFP-RAB25(T26N) and
immunostained for collagen IV (top rows). Confocal ﬂuorescence photomicrographs of control shRNA cells, co-transfected with LH3-mCherry, GFP-RAB10
and untagged dominant-negative RAB25(T26N) (immunostained overexpressed, bottom row). Colocalization between collagen IV and LH3-mCherry for
both a,b as well as between LH3-mCherry and overexpressed RAB25 (a), and LH3-mCherry and GFP-RAB10 (b) was measured by the Pearson’s coefﬁcient
(upper graph: þ RAB25, n¼ 6; þ RAB25(T26N), n¼9 of pooled data set of two independent experiments; P¼0.0022 using Mann–Whitney, two-tailed).
(Lower graph: þRAB25(T26N), n¼8 of pooled data set of two independent experiments). In a,b error bars represent s.d. Figures show representative
images. Scale bars, 10mm. ***Pr0.001.
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Figure 6 | Knockdown mIMCD3 cells share molecular and cellular phenotypes. (a) Total cell lysates from mIMCD3 cell lines were analysed by western
blot with antibodies against collagen IV, E-cadherin and b-actin. Uncropped western blots are shown in Supplementary Fig. 13a. (b) mIMCD3 cell lines were
grown on transwell supports for 2 weeks and immunostained with anti-collagen IV antibody. Figures show representative images of three independent
experiments of n¼ 3 views of multiple cells each. Scale bars, 10mm. (a,b) Repeated three times. Representative images are shown. (c) mIMCD3 cell lines
cultured for 3 days in 3D collagen I gels, immunostained with anti-E-Cadherin and anti-Claudin-1 antibodies. Scale bars, 10 mm. (d) EM of 3D cultured
mIMCD3 cells (top panels), scale bars, 20mm. Higher magniﬁcation of the areas of abnormal extracellular matrix deposits in kd cells (bottom panels).
Representative images of n¼ 9 (Control shRNA), n¼ 7 (VIPAR shRNA), n¼ 9 (VPS33B shRNA) and n¼8 (LH3 shRNA) spheres are shown. Scale bars,
1mm. (e) LC-MS-MS analysis for the relative quantiﬁcation of the degree of Lys-O-GalGlc, Lys-O-Gal and Lys-OH in collagen IV from mIMCD3 cell lines.
Two different control lines (wt and Control shRNA) and two different VIPAR shRNA clones were used. LH3 shRNA cells were used as a positive control.
(f) Differentially expressed genes in kd mIMCD3 cell lines were detected using a moderated t-test implemented in the limma package in R34. The top 100
genes based on P value were selected and compared across the three kds.
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set enrichment analysis36,37 was then used to highlight the
cellular processes perturbed in the kd cell lines by looking for
gene sets with a larger than expected number of differentially
expressed genes. Interestingly, the overlapping ’Axon guidance’
and ’Semaphorin interactions’ gene sets were the most
signiﬁcantly enriched sets for all three kd cell lines
(Supplementary Table 3).
Collagen defects in ARC patients and murine models. ARC
syndrome caused by VPS33B or VIPAR deﬁciencies results in
abnormal kidney and liver function, extremely dry skin (ich-
thyosis), defective platelet a-granule biogenesis, osteopaenia and
recurrent bone fractures, and death in infancy in the majority of
patients. We generated inducible Vps33b (Vps33bﬂ/ﬂ-ERT2) ko
mice because of embryonic lethality of constitutive Vps33b ko at
E7.5 and recently described haematological defects that accurately
model abnormalities found in ARC patients’ platelets38. Neither
Vps33bﬂ/ﬂ-ERT2 nor the de novo generated inducible Vipas39
(Vipas39ﬂ/ﬂ-ERT2) ko mice showed visceral abnormalities;
however, both ko’s developed dry, scaly skin and hair loss 4
weeks after induction. Cultured osteoblasts derived from
tamoxifen-induced Vps33bﬂ/ﬂ-ERT2 and Vipas39ﬂ/ﬂ-ERT2 mice
demonstrated successful ko (Supplementary Fig. 5c). As it was
previously shown that LH3-mediated glycosylation of procollagen
I is crucial for crosslink formation, ﬁbrillogenesis and bone
mineralization39, we euthanized the animals to analyse collagen I
structure and function in the tail tendons. Atomic force
microscopy (AFM) and scanning electron microscopy (SEM) of
collagen I from Vipas39 ﬂ/ﬂ-ERT2 and Vps33bﬂ/ﬂ-ERT2 male and
female pooled mouse tendons showed swelling and distortion of
the ﬁbrils, lack of cohesion, crimping and disordered ﬁbrils
compared with control mice that displayed normal D-banding
with a consistently regular and aligned ﬁbrils (Fig. 8a,b and
Supplementary Fig. 8). Although the ﬁbrillar D-banding period
did not statistically vary (P¼ 0.32 using one-way analysis of
variance) between control (D¼ 67.8±1.0) nm and Vipas39 ﬂ/ﬂ-
ERT2 (D¼ 65.0±2.3) nm and Vps33bﬂ/ﬂ-ERT2 (D¼ 64.1±1.9)
nm when measured by two-dimensional (2D) Fast Fourier
transform (FFT) of AFM images (N¼ 7), localized variations in
the shape of the banding were apparent (Fig. 8a) in the case of
both Vipas39 ﬂ/ﬂ-ERT2 and Vps33bﬂ/ﬂ-ERT2. These data suggest a
disparity in the quaternary collagen I structure in the ko mice.
Cultured skin ﬁbroblasts derived from ﬁve ARC patients with
different VPS33B and VIPAS39 mutations were analysed, and
consistent procollagen I accumulation was found in patients’
ﬁbroblasts compared with controls (Fig. 8c). Defects in LH3-
dependent lysine modiﬁcations were identiﬁed in patients’
ﬁbroblasts grown in the presence of ascorbic acid compared with
the age-matched control (Fig. 8d). The difference in collagen
lysine hydroxylation (also performed by LH1 and LH2) was less
pronounced when compared with LH3-speciﬁc modiﬁcations,
suggesting that the defect is LH3-speciﬁc. In addition, testing
urine available from three different ARC patients with known
mutations in VPS33B showed a substantial decrease in all LH3-
dependent post-translational lysine modiﬁcations compared with
age-matched controls (Fig. 8e).
Discussion
We have demonstrated that LH3 targeting from the TGN to the
newly described collagen IV-containing organelles is regulated by
VIPAR and its interacting proteins. In silico modelling and
co-immunoprecipitation experiments allowed us to identify the N
terminus of VIPAR as a novel indirect interactor of LH3, while
the VIPAR C terminus stably interacts with its molecular partner
VPS33B. Contradicting reports provide room for controversy
regarding the potential roles for different homologues of yeast
VPS33 and VPS16 in HOPS and/or CORVET function in
endocytosis and autophagy20,23,40–42. Our study proposes that
VIPAR and VPS33B, in association with RAB10 and RAB25, are
involved in a novel post-Golgi LH3 trafﬁcking pathway. VIPAR,
in complex with VPS33B, may have a role in RAB10/RAB25
conversion on post-Golgi vesicles, similar to HOPS and CORVET
regulation of RAB5/RAB7 conversion in endocytosis43,44, and
may assist membrane tethering by interacting with SNARE
proteins. To conﬁrm the importance of this new pathway to
collagen homeostasis, we have demonstrated that VPS33B and
VIPAR deﬁciencies result in abnormal LH3-dependent post-
translational modiﬁcation of collagen IV in a murine kidney cell
line, and procollagen I in ARC patients’ skin ﬁbroblasts.
Furthermore, a reduction in LH3-speciﬁc modiﬁcations was
detected in ARC patients’ urine, and structural defects in collagen
I were found in tail tendons from VPS33B- and VIPAR-deﬁcient
mice. The collagen abnormalities identiﬁed in skin ﬁbroblasts and
tendons consistent with the characteristic ARC features of
ichthyosis, arthrogryposis, osteopaenia and bone fractures suggest
an important role for VPS33B- and VIPAR-dependent LH3
trafﬁcking in connective tissue.
Gene expression analysis provided insight into the possible
regulatory mechanisms responsible for the cell morphology
defects and detected high similarity between the proﬁles in
VPS33B-, VIPAR- and LH3-deﬁcient cells with dysregulation of
‘axon guidance’ and ‘semaphorin interactions’ overlapping gene
sets. Semaphorins initiate signals to the cytoskeleton that regulate
the organization of actin ﬁlaments and the microtubule net-
work45. The genes incorporated into this set have recently been
implicated in cancer progression as they can inﬂuence cell
behaviour by activating plexins or inhibiting the interactions of
growth factors46. In addition, a recent report suggested that LH3
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might be involved in recruitment of matrix metalloproteinase 9,
which plays a prominent role in ECM remodelling and TGF-beta
activation47.
We therefore present evidence that regulation of LH3-collagen
modiﬁcation by this novel VIPAR-dependent trafﬁcking pathway
is crucial for cell differentiation and tissue morphogenesis.
Further work is required to demonstrate why collagen IV carriers
are the preferred location for the LH3-dependent collagen IV
modiﬁcation and whether they have a role in homeostasis of
other basement membrane components.
Methods
DNA constructs. Mouse-speciﬁc pRS plasmid shRNA constructs (VIPAR:
TI594651, LH3: TI541624) and pRS control shRNA (TR30012) were obtained from
Origene (Cambridge Biosciences, UK).
Plasmids generated previously20 containing tagged full-length VIPAS39,
VPS33B and endosomal markers cDNA were used for immunoﬂuorescence and co-
immunoprecipitation experiments. Short constructs of VIPAR used for co-
immunoprecipitation experiments (Fig. 1b,c) were cloned in pCMV-Myc vector
using the primer sequences and restriction enzymes described in Supplementary
Table 4. Full-length human PLOD3 cDNA was obtained from Source Bioscience
and was cloned into pmCherry N1 vector using the primer sequences and
restriction enzymes described in Supplementary Table 4. GFP-Rab10 was a gift
from D. Cutler (MRC Laboratory for Molecular Cell Biology, UCL, UK). Rab25-
and Rab10-dominant-negative mutants GFP-Rab25(T26N) and GFP-
Rab10(T23N) were created using Quick-change XL site-directed Mutagenesis Kit
(Agilent Technologies, UK). GFP-LC3 plasmid was a gift from R. Ketteler (MRC
Laboratory for Molecular Cell Biology, UCL, UK). Plasmids of the pUPE series
used for afﬁnity-tagged recombinant expression of VPS33B and VIPAR in HEK293
cells were provided by U-protein Express BV (U-PE, the Netherlands) and cloned
using the conditions reported in Supplementary Table 4. pEGFP-Rab11a and the
dominant-negative Rab11a plasmid pEGFP-Rab11aDN, containing the S25N
missense mutation, were gifts from F. Barr (University of Oxford, UK). Rab25
cDNA was custom-synthesized by Euroﬁns MWG Operon (London, UK) and
cloned into pEGFP-C3 vector backbone using EcoRI and Kpn1 restriction
enzymes.
Mammalian cell culture and transfection. All cell culture reagents were from
Sigma-Aldrich, UK, unless otherwise stated. Human skin ﬁbroblasts, HEK293 and
HeLa cells (not authenticated, both gift from E.R. Maher, Department of Medical
Genetics, University of Cambridge, UK) were maintained in high-glucose
(4.5 g l 1) DMEM supplemented with 10% fetal bovine serum (FBS), 2mM
L-glutamine and 100mM MEM nonessential amino-acid solution at 37 C and 5%
CO2. For mass spectrometry analysis of post-translational modiﬁcations, post-
conﬂuent ﬁbroblasts were grown in the presence of ascorbic acid (100 mM) for
3 weeks. mIMCD3 cells (American Type Culture Collection CRL2123) were
cultured in a 1:1 mix of DMEM and Ham’s F-12 medium, supplemented with 10%
FBS. All cell lines were regularly tested for the lack of mycoplasma contamination
using the MycoAlert Mycoplasma Detection Kit (Lonza, UK).
For microscopy experiments, cells were seeded either on eight-well tissue
culture-treated m-Slides (IBIDI, Thistle Scientiﬁc, UK) or on glass coverslips. For
live imaging IBIDI 35-mm cell culture-treated dishes were used.
For protein extraction, cells were cultured in plastic multiwell plates (Corning,
UK) or 75-cm2 ﬂasks (Corning). For collagen IV analysis, mIMCD3 cells were
plated onto 0.4-mm-pore Transwell-permeable supports (Corning) at 1 105
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Figure 8 | Abnormal collagen modiﬁcation and structure in VPS33B- and VIPAR-deﬁcient mouse models and patients. (a) AFM of mouse tail tendon
collagen I from control, Vipas39 ﬂ/ﬂ-ERT2 and Vps33bﬂ/ﬂ-ERT2 male and female mice. Scale bar, 400 nm. (b) SEM of mouse tail tendon collagen I from
control, Vipas39 ﬂ/ﬂ-ERT2 and Vps33bﬂ/ﬂ-ERT2 mice. Scale bar, 20mm. For a,b representative images from three independent experiments with three animals
per group are shown. (c) Total cell lysates of human skin ﬁbroblasts derived from ARC patients and age-matched controls were immunoblotted with
antibodies against procollagen I and -actin, and densitometry was carried out. Levels of procollagen I in ARC patient ﬁbroblasts were measured relative to
control I in the ﬁgure. Uncropped western blots are shown in Supplementary Fig. 13b. (d) LC-MS-MS analysis for the relative quantiﬁcation of Lys-O-GalGlc,
Lys-O-Gal and Lys-OH in collagen I from human skin ﬁbroblasts derived from ARC patients with different VPS33B and VIPAS39 mutations and an age-
matched control. Error bars represent s.d. from two experimental repeats. (e) LC-MS-MS of urine analysed for LH3-dependent collagen lysine modiﬁcations
in three different ARC patients and age-matched controls (n¼ 19). Error bars represent s.d.
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cells cm 2 to allow the cells to fully polarize. For CLEM experiments, cells were
grown on 35-mm photo-etched gridded glass-bottomed dishes (MatTek Corp,
Ashland, USA).
Cells were transfected with plasmid DNA using Lipofectamine 2000 according
to the manufacturer’s protocol (Life Technologies, UK). For CLEM, cells were
transfected with jetPRIME (Polypus Transfection, USA). HeLa and HEK293 cells
were seeded 24 h before transfection at a density of 2.5 105ml 1. mIMCD3 cells
were seeded 3 h before transfection at the density of 2.5 105ml 1.
Stable kd’s of VPS33B, VIPAS39 or PLOD3 were achieved by transfecting
mIMCD3 cells with 4 mg of predesigned shRNA and allowed to recover for 48 h
before selection of individual clones with puromycin (1.5 mgml 1)20. For
mIMCD3 sphere formation, Geltrex was prepared according to the manufacturer’s
protocol (Life Technologies) before 2 104 cells were seeded per well of an eight-
well m-Slide. Spheres were cultured for 4 days before either immunostaining or
processing for electron microscopy (EM).
Antibodies and reagents. All chemicals and antibodies were from Sigma-Aldrich
unless otherwise stated. Antibodies used in this study include the following: mouse
monoclonal anti-c-Myc clone 9E10 (M4439, 1:5,000 for western blot (WB) and
1:400 immunoﬂuorescence (IF)); mouse monoclonal anti-haemagglutinin (HA)
clone HA-7 (H3663, 1:1,000 for WB); mouse anti-b-actin (A5441, 1:15,000 for
WB); rabbit polyclonal anti-Claudin-1 (71-7800, 1:400 for IF, Life Technologies);
mouse monoclonal anti-E-cadherin (610181, 1:250 for IF, BD Transduction, UK);
sheep polyclonal anti-TGN46 (AHP500GT, 1:1,000 for IF, Bio-Rad, UK); mouse
monoclonal anti-GAPDH (ab8245, 1:10,000 for WB, Abcam, UK); rabbit poly-
clonal anti-collagen IV (ab6586, 1:200 for IF, 1:1,000 for WB, Abcam); rabbit
polyclonal anti-Golgin97 (ab84340, 1:100 for IF, Abcam); rabbit polyclonal anti-
GFP (ab290, 1:2,000 for WB, Abcam); chicken polyclonal anti-Calreticulin
(ab14234, 1:400 for IF, Abcam); mouse monoclonal anti-g-Adaptin (A4200, 1:100
for IF); mouse monoclonal anti-PDI (ab2792, 1:100 for IF, Abcam); rabbit poly-
clonal anti-collagen I (NB600-408, 1:1,000 for WB, Novus Biological, UK); rabbit
polyclonal anti-LH3 (11027-1-AP, 1:50 for IF, 1:500 for WB, Proteintech, USA);
rabbit polyclonal anti-VIPAR (HPA003589, 1:50 for IF, 1:500 for WB); rabbit
polyclonal anti-RAB25 (4314S, 1:100 for IF, Cell Signaling Technology, USA—the
recognition of dominant-negative RAB25(T26N) form by this antibody was ver-
iﬁed). Rat polyclonal anti-VPS33B antibody (1:200 for WB, Eurogentec, Belgium)
was raised against two peptides (peptide 1: QYDRRRGMDIKQMKN; peptide 2:
ITENGLIPKDYRSLK) and afﬁnity-puriﬁed. All secondary antibodies used for
immunoﬂuorescence were Alexa Fluor conjugates (Life Technologies). 40 ,6-dia-
midino-2-phenylindole (DAPI) was used for nucleus counterstaining where
possible.
When necessary, Alexa Fluor 568 was used for the anti-LH3 antibody labelling
using the Zenon Labeling Kit (Life Technologies) according to the manufacturer’s
protocol. This was then used in combination with anti-VIPAR antibody also
produced in rabbit. Controls included the omission of the primary antibody and
staining of HeLa cells.
Protein extraction and quantiﬁcation. For standard protein extraction, cells were
grown to conﬂuence in either 75-cm2 ﬂasks or six-well plates. Cells were rinsed
twice with ice-cold PBS and scraped into 250 ml of RIPA lysis buffer (50mM Tris-
HCl, 150mM NaCl, 1mM EDTA, 1% Igepal CA-630, 0.5% sodium deoxycholate,
0.1% SDS and complete mini protease inhibitor cocktail (Roche, Switzerland)). Cell
lysates were centrifuged at 14,000g for 15min at 4 C and supernatants were
immunoblotted according to the standard protocols20. When required the band
intensities were scanned and quantiﬁed using the densitometry function of
ImageJ48.
Co-immunoprecipitation. For immunoprecipitation of collagen I, human skin
ﬁbroblasts were grown on T-75 ﬂasks for 4 weeks with replacement of medium
twice per week. mIMCD3 cells were cultured on Transwell supports for 3 weeks
before immunoprecipitation of collagen IV was performed. HEK293 cells were
grown on six-well plates and transfected with a total of 4 mg of plasmid DNA per
well. Immunoprecipitation was performed 48 h post transfection. All cells were
lysed in 300 ml of NP-40 lysis buffer (0.3% NP-40, 10mM HEPES pH 8.5, 10mM
KCl, 5mM MgCl2, 1mgml 1 DNase, 5mM dithiothreitol (DTT), Protease inhi-
bitors). The mixture was incubated with gentle rotation at 4 C for 30min, and
after sonication the lysate was clariﬁed by centrifugation at 14,000g for 15min at
4 C. For immunoprecipitation of collagen I, collagen IV, myc- or HA-tagged
proteins, 8 mg of, respectively, anti-collagen I, anti-collagen IV, anti-myc or anti-
HA antibody was conjugated to 20 ml of Dynabeads Protein G (Life Technologies)
according to the manufacturer’s instructions. Lysates were mixed with 20 ml of
antibody-conjugated Dynabeads and incubated overnight at 4 C on a blood rotor
with end-over-end mixing. Immunoprecipitated proteins were then washed three
times using cell lysis buffer and eluted by boiling the complexes in lysis buffer
supplemented with 5 SDS loading buffer for 5min. Samples were then analysed
by western blotting for detection of protein–protein interactions. Immunopreci-
pitates of collagens I and IV were further processed for mass spectrometry analysis
as described below.
Collagen elution and digestion with Pronase E. Collagens IV and I were
immunoprecipitated as described above. After three washes with NP-40 lysis
buffer, dried Dynabeads were incubated for 1 h at room temperature with 200 ml
FAPS elution solution (50% formic acid, 25% acetonitrile, 15% isopropanol and
10% water) to remove the afﬁnity-puriﬁed collagen. Samples were then dried with a
centrifugal evaporator (Christ 2-18 HCl) and rehydrated with 100 ml of phosphate
buffer (pH 7.4). Subsequently, collagen was digested with 50 ml of 5mgml 1
Pronase E in phosphate buffer for 6 h at 37 C by shaking. Samples were further
digested with 100 ml of Pronase E for 16 h and additional 50 ml for 6 h.
Tandem mass spectrometry measurement of lysine modiﬁcations. A Waters
Acquity Ultra Performance Liquid Chromatography (UPLC) coupled to a Xevo
TQ-S Triple Quadrupole Mass Spectrometer (Waters Corp, UK) and stable isotope
internal standards were used to develop a rapid 5-min test for the quantitation of
glucosylgalactosyl hydroxylysines (Lys-O-GalGlc), galactosyl hydroxylysines (Lys-
O-Gal) and hydroxylysines (Lys-OH).
Lys-O-GalGlc and Lys-O-Gal standards were obtained as a kind gifts from
Professor Ruggero Tenni (University of Pavia, Italy). A stable isotope-labelled
lysine (13C615N-lysine) was used for quantitation of all targeted metabolites. The
instrument was operated in a negative ion mode and standards (10mmol l 1) were
infused into the electrospray source at a ﬂow rate of 25 ml min 1 to determine
parent and product ion m/z; optimum cone and collision energies of the MRM
assay (MS-operating parameters are shown in Supplementary Table 1).
The capillary voltage was maintained at 3.7 kV, with source temperature held
constant at 150 C and nitrogen used as the nebulizing gas at a ﬂow rate of 30 l h 1.
The masses were determined for each amino acid in the scan mode over the mass range
of m/z 200–1,200. Product ions were determined over a mass range of m/z 50–950
following collision-induced dissociation and using argon as the collision gas.
UPLC liquid chromatography parameters. A UPLC proﬁle was created and
optimized to these transitions using an ACQUITY UPLC 2.1 50mm BEH C8
1.7-mm column (Waters Corp). The peptide elution gradient consisted of a total of
5min starting from 5 to 67% acetonitrile: 33% methanol over 4min and back to 5%
acetonitrile for 1min for re-equilibration. Flow rates were 0.8mlmin 1 at a col-
umn temperature of 40 C.
FMOC-derivatization of amino acids for UPLC-MS/MS analyses. The collagen-
derived amino acids Lys, Lys-OH, Lys-O-GalGlc and Lys-O-Gal and 13C615N-Lys
were derivatized before mass spectrometry with Fluorenylmethyloxycarbonyl
chloride (FMOC-Cl) following the established protocols49. Calibration curves were
used for quantitation of collagen-derived amino acids over the range 100 nmol to
100 mmol. The degree of collagen modiﬁcation was determined by rationing the
collagen-derived amino-acid response to the 13C615N-Lys internal standard for each
collagen-derived amino acid described. For the relative quantiﬁcation to the
amount of collagen, these values were ratioed to the degree of the Lysine response.
All data were analysed using MassLynx and TargetLynx (Waters Corp), GraphPad
Prism and Microsoft Excel. All samples for each group were analysed in triplicate.
Two-tailed Mann–Whitney P valueo0.05 was considered signiﬁcant.
Immunoﬂuorescence and confocal microscopy. HeLa cells and ﬁbroblasts were
ﬁxed with 4% paraformaldehyde in PBS for 20min and then permeabilized with
0.1% Triton X-100 in PBS. Cells were blocked with 2% BSA in PBS with 0.05%
Tween 20. mIMCD3 spheres in Geltrex were methanol-ﬁxed for 5min at  20 C,
blocked with 2% BSA with 0.5% Saponin in PBS and stained for E-cadherin and
Claudin-1, with DAPI counterstaining. Coverslips were mounted in ProLong Gold
anti-fade solution (Life Technologies). Cells in m-Slides were imaged in PBS.
Confocal microscope images with scan format of 1,024 1,024 pixels were
captured using an inverted Leica TCS SP5 AOBS confocal microscope with a  63
oil immersion objective (numerical aperture (N.A.) 1.4) and a  3.5 optical zoom;
the pinhole was set to 1 Airy unit. Single transfections of cyan ﬂuorescent protein
(CFP)- or yellow ﬂuorescent protein (YFP)- were used to control the leak-through
between the channels. A series of optical sections was collected at 0.25 mm z-
spacing and processed using Fiji50. Single xz images with the scan format of
1,024 1,024 pixels were also obtained in the middle plane of 3D spheres with a
 40 oil immersion objective (N.A. 1.25). Representative images are shown in all
experiments. Colocalization was determined using the Fiji plugin JACoP and was
represented by Pearson’s coefﬁcient calculated on the 3D projection of entire cells,
after Costes randomization and automatic threshold calculation51.
Electron microscopy. Cells in 2D and 3D cultures were ﬁxed using 2% paraf-
ormaldehyde and 1.5% glutaraldehyde in 0.1M sodium cacodylate before being
incubated with 1% osmium tetroxide and 1.5% potassium ferricyanide at 4 C. They
were further treated with 1% tannic acid before being serially dehydrated in ethanol
and embedded in Epon (TAAB). Ultrathin sections (70nm) were taken using a Leica
UC7 ultramicrotome (Leica Microsystems, Austria) and collected on formvar-coated
slot grids. Sections were lead citrate-stained and then imaged using a Tecnai T12
Spirit Biotwin (FEI, the Netherlands) and Morada CCD camera using imaging
platform for transmission electron microscopy (iTEM software; EMSIS, Germany).
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Correlative light and electron microscopy. Control and VIPAR shRNA-treated
mIMCD3 cells were grown and transfected with LH3-mCherry as described above.
Cells were then ﬁxed with 4% paraformaldehyde in PBS and imaged using an
inverted Leica TCS SPE AOBS confocal microscope. Dissolved inorganic carbon
(DIC) and ﬂuorescent (568 nm) images were taken using a  20 dry objective to
identify transfected cells in relation to the grid, and confocal stacks using a  40
objective (N.A. 1.14) to localize individual LH3-mCherry puncta within the
transfected cells in xyz. Cells were then ﬁxed and prepared for EM as described
above. Once embedded, the cells of interest were relocated on to the block surface,
and 70-nm serial ultrathin sections were collected on formvar-coated slot grids and
then stained with lead citrate. Regions of interest in each cell were identiﬁed by
overlaying DIC and ﬂuorescence images over low-magniﬁcation images of early
sections. These areas were then imaged at higher magniﬁcation for every section
before being aligned digitally in Adobe Photoshop. High-magniﬁcation correlation
of light microscopy and electron microscopy data was performed using char-
acteristic features in the DIC images. Temporal colour-coding of the ﬂuorescence
data was performed to conﬁrm the correlation of puncta in z between the light and
EM data. iTEM was used to measure the diameter of LH3-positive structures at
their predicted equator.
CLEM on LH3 coupled to DAB-staining for collagen IV. Immunoperoxidase and
DAB (–TAAB, UK) staining for CLEM was performed following the established
protocols52,53. Brieﬂy, control mIMCD3 cells were transfected with LH3-mCherry,
ﬁxed with 4% paraformaldehyde (PFA) in PBS for 50min at room temperature and
imaged as described above. Cells were then washed three times with PBS and
incubated with buffer A (0.5% BSA, 50mM NH4Cl, 0.1% saponin in PBS) for
30min and stained with collagen IV antibody (1:20 dilution) for 2 h at room
temperature. Subsequently, cells were washed three times with buffer A and
incubated with hoprseradish peroxidase-conjugated anti-Rabbit IgG (DAKO,
Denmark) for 1–2 h. After three washes in PBS, cells were ﬁxed with 1.5%
glutaraldehyde in 0.1M sodium cacodylate supplemented with 5% sucrose for
50min at room temperature. Cells were rinsed three times with 50mM Tris-HCl
buffer, pH 7.6.
The peroxidase reaction was developed by incubating cells in the dark with the
DAB reaction mix (0.07% H2O2, 0.075% DAB in Tris-HCl buffer) for 10min. The
generation of reaction product was monitored by light microscopy. To stop, the
reaction cells were rinsed three times with Tris-HCl buffer. Cells were then
prepared for EM, imaged and analysed as described above.
Microarray analysis of kd mIMCD3 cell lines. The transcriptome of VPS33B,
VIPAR and LH3 shRNA mIMCD3 cell lines was investigated by hybridizing RNA
to Affymetrix GeneChip Mouse Gene 2.0 ST arrays following the recommended
Affymetrix protocols. The data were pre-processed with standard RMA normal-
ization and summarization using the oligo R package54. Principal component
analysis and various distance metrics were used to ensure that the data were of high
quality and clustered into the expected experimental groups. Microarray analysis
was also carried out in wild-type and control shRNA mIMCD3 cells and results
from both sets were compared with the kd cell lines. Differentially expressed genes
were identiﬁed by ﬁtting a linear model to each gene using the limma package in
R34. P values were adjusted for multiple testing using the Benjamini–Hochberg
correction and a cutoff of false discovery rate (FDR) o0.05 was applied.
GO annotation analysis was carried out using the online software DAVID35 by
inputting the lists of signiﬁcantly differentially expressed genes. The Mus musculus
genome was used as the background. The GO FAT annotations were used, in
which very broad GO terms are ﬁltered out.
As a simple way to compare the similarity of the gene expression across the
microarrays, pairwise correlations were computed across the microarrays and
plotted in a correlogram. Lists of the top 100 most differentially expressed genes in
each kd were also compared for overlap, shown in a Venn diagram (Fig. 6f). The
statistical signiﬁcance of the overlap between each pair of kd’s was computed based
on the hypergeometric distribution for the probability of k or more (k¼ 62, 62 or
66) genes overlapping when 100 genes are selected from a background of 12,055
genes. P values were highly signiﬁcant (Po1 10 112). To approach the question
of which cellular processes are perturbed, gene set enrichment analysis36,37 was
used to identify gene sets that have a larger than expected number of differentially
expressed genes. The squared regularized t-statistic was used as the individual gene
statistic, and then a summary statistic was computed for each gene set based on the
mean for all the genes in that set. Signiﬁcance was assessed by randomly sampling
gene sets of the same size and computing an approximate P value.
Structural bioinformatics. Secondary structure prediction on VPS33B, VIPAR
and LH3 was performed by comparing the results of multiple web servers including
HHPRED55 and PredictProtein56. Intrinsic disorder and ﬂexibility of the VIPAR N
terminus were further evaluated using multiple protein disorder web servers57. The
presence of potential transmembrane helices in this region was excluded by
thorough evaluation of the results from various servers for transmembrane protein
prediction including TMHMM58 and HMMTOP59. Thorough comparison of
multiple structural prediction algorithms enabled unambiguous identiﬁcation of
the most prominent features of the proteins analysed.
The 3D models of the VIPAR C terminus and full-length VPS33B were created
using HHPRED and MODELLER60. The model of the VPS33B–VIPAR complex
was generated by superposing the structural models of VIPAR and VPS33B to the
available crystal structures of human VPS33A-VPS16 (PDB ID: 4BX9)23 and
Chaetomium thermophilum VPS33–VPS16 (PDB ID: 4KMO)24 using the software
COOT61. The model was further optimized by geometry idealization using
PHENIX62. Final model quality was assessed using PROCHECK, PDBSUM63 and
the Qmean server64.
Recombinant tagged VPS33B–VIPAR expression and puriﬁcation. Recombi-
nant tagged VPS33B–VIPAR complexes were produced in HEK293 cells stably
expressing Epstein-Barr virus Nuclear Antigen I (ref. 65). Initial attempts to
produce isolated VPS33B or VIPAR resulted in low recombinant protein yields that
could be signiﬁcantly improved by co-transfecting the VPS33B and the VIPAR
expression plasmids. Cultures were harvested 5–6 days later by centrifugation at
1,000g. Cells were resuspended in cold hypotonic solution (10mM HEPES, 10mM
KCl, 5mM MgCl2, pH 8.5) in 1/10 of the total culture volume and lysed by adding
0.3% NP-40. After high-speed centrifugation, the soluble fractions were collected
and analysed using western blotting for evaluation of protein production. After
extensive small-scale expression scouting for the most suitable combinations of
puriﬁcation tags, constructs pUPE.02.09-VIPAR (bearing N-terminal His6StrepII3-
tag) and pUPE.02.13-VPS33B (bearing N-terminal His6cmyc4-tag) were selected
for large-scale expression. Large-scale expression cultures were performed in
shaking ﬂasks, and the cells were harvested 6 days from transfection. After lysis and
high-speed centrifugation, the soluble fractions were collected, NaCl was added to
reach a ﬁnal concentration of 300mM and the sample was incubated with Strep-
tactin Sepharose beads (GE Healthcare, USA) for 2 h. The beads were then packed
into a column, washed extensively with buffer, and then eluted by supplementing
the incubation buffer with 2.5mM desthiobiotin. The eluted sample was con-
centrated using VivaSpin centrifugal ﬁlter devices (Sartorius, Germany) and
injected into a Superdex 200 10/300 GL gel ﬁltration column (GE Healthcare). The
VPS33B–VIPAR complex eluted as a single peak. Samples were concentrated to
3mgml 1 and stored at  80 C for future usage. During the co-puriﬁcation of
overexpressed VPS33B and VIPAR, we consistently observed additional bands in
SDS–PAGE analysis. The puriﬁed sample was therefore subjected to mass spec-
trometry analysis.
In-solution trypsin digestion and LC-MS/MS analyses. The recombinant tagged
VPS33B–VIPAR complex with the captured protein was ﬁrst denatured with 20 mL
of 100mM Tris-HCl, pH 7.2, 6M urea and 5M dithioerythreitol for an hour at
room temperature before being carboamidomethylated for 45min with 6 mL of
100mM Tris-HCl, pH 7.8, 5M iodoacetamide. The ﬁnal product was the digested
for 12–16 h at 37 C with 1 mg of sequence-grade trypsin in dH2O (ref. 66). The
supernatant containing the peptides was removed after centrifugation of the sample
mixture and transferred to an injection vial for analysis in the mass spectrometer.
MSi low/high collision energy-induced scanning was performed following the
established protocols66. All analyses were performed using a nanoAcquity UPLC
and quadrupole time-of-ﬂight (Q-TOF) Premier mass spectrometer (Waters Corp).
Peptides were separated before mass spectral analysis using a 15 cm 75m C18
reverse-phase analytical column.
Peptides were analysed in positive ion mode. Post calibration of data ﬁles was
corrected using the doubly charged precursor ion of [glu1]-ﬁbrinopeptide B (m/z,
785.84262þ ).
Data analysis of samples analysed by Q-TOF MS/MS. ProteinLynx Glo-
balServer version 2.5 was used to process all data acquired. Protein identiﬁcations
were obtained by searching the UniProt reference human proteome with the
sequence of pig trypsin (P00761) added. Protein identiﬁcation from the MS/MS
spectra for each sample was processed using a hierarchical approach where more
than three fragment ions per peptide, seven fragment ions per protein and more
than two peptides per protein had to be matched. Carboamidomethylation of
cysteines was used as a ﬁxed modiﬁcation.
Animal models. For Vipas39ﬂ/ﬂ-ERT2 mouse generation, targeted ES cells for
Vipas39 were obtained from the KOMP Repository (www.komp.org), a NCRR-
NIH-supported mouse strain repository (U42-RR024244). ES cells from which this
mouse was generated were created by the UCSD consortium from funds provided
by the trans-NIH KnockOut Mouse Project (KOMP; Grant #5U01HG004080). The
chimeric mice containing the ‘Knockout First, Conditional Ready’ Vipas39tm1a(-
KOMP)Mbp allele, with LoxP sites ﬂanking Vipas39 exon 10 and a reporter-tagged
insertion cassette, were mated with C57BL/6J mice and screened for germline
transmission. Heterozygous Vipas39þ /tm1a(KOMP)Mbp mice on a C57BL/6J back-
ground was crossed with ‘ﬂippase deleter’ Flpþ /þ mice to remove the reporter-
tagged insertion cassette. The resultant conditional Vipas39þ /ﬂ-Flpþ / mice were
further crossed with CreERT2-recombinase-expressing mice (Jackson Laboratories,
USA) to introduce tamoxifen-inducible Cre recombinase expression. Vipas39þ /ﬂ-
Flp /ERT2þ offspring were further mated to obtain Vipas39ﬂ/ﬂ-ERT2 mice.
The removal of Vipas39 exon 10 was induced by intraperitoneal injections of
100mg kg 1 per day tamoxifen for ﬁve consecutive days on 6–8-week-old mice.
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Controls used were either Vipas39ﬂ/ﬂ-ERT2 mice not induced with tamoxifen or
Vipas39ﬂ/ﬂ mice without Cre recombinase that had been treated with tamoxifen.
Vps33bﬂ/ﬂ-ERT2mouse generation was performed in a similar manner to
Vipas39ﬂ/ﬂ-ERT2mice38. Controls used were either Vps33bﬂ/ﬂ-ERT2 mice not
induced with tamoxifen or Vps33bﬂ/ﬂ mice without Cre recombinase that had been
treated with tamoxifen.
All analyses were performed 5–6 weeks post induction, adding some potential
variability because of different mouse age and induction length.
All procedures were undertaken with United Kingdom Home Ofﬁce approval
(licence number PPL 70/7470) in accordance with the Animals Scientiﬁc
Procedures Act of 1986.
Detection of Vps33b and Vipar expression in murine osteoblasts. Osteoblasts
were isolated from control, Vps33bﬂ/ﬂ-ERT2 and Vipas39ﬂ/ﬂ-ERT2 murine long
bones using the following protocol67.
Long bones were isolated from one to two adult mice for each group and
epiphyses were cut off before the bone marrow was ﬂushed out with PBS using a
5-ml syringe and a 27-gauge needle. Diaphyses were cut using scissors into pieces
of 1–2mm2 and washed thoroughly with PBS before incubation in 4ml collagenase
II solution at 37 C in a shaking incubator for 2 h, with vigorously shaking
manually every 30min. Bone fragments were then washed three times with cCM
media (DMEM supplemented with 10% FBS, 100Uml 1 penicillin, 50mgml 1
streptomycin sulfate, 50 mgml 1 gentamycin, 1.25 mgml 1 fungizone and
100mgml 1 ascorbate). About 20–30 fragments were transferred to a 25-cm2
ﬂasks and evenly distributed with 5ml of cCM. The media (freshly prepared each
time) was changed three times per week for 2 weeks. Osteoblasts migrated from the
bone fragments were lysed as above and whole-cell lysates were immunoblotted
with anti-VIPAR and anti-VPS33B antibodies.
Scanning electron microscopy. A minimum of three tails from individual mice
per ko condition were selected, with no less than three tendon extract samples for
each tails. For each tendon extract, seven images per location were taken. Tails were
selected randomly from each mouse to avoid selection bias. Male and female
control, Vps33bﬂ/ﬂ-ERT2 and Vipas39ﬂ/ﬂ-ERT2 mice tendon extracts were separated
into short (B0.5 cm) lengths. These were then ﬁxed for 24 h in 3% glutaraldehyde
(Agar Scientiﬁc, UK) in 0.1M sodium cacodylate solution. Samples were then
dehydrated using an ethanol series before critical point drying with hexam-
ethyldisilazane (HDMS). Samples were mounted using carbon-adhesive tabs to
aluminium stubs (Agar Scientiﬁc) and coated in Au/Pd. Imaging for qualitative
analysis was performed using a Philips XL30 FEG-SEM (FEI), with an accelerating
voltage of 5 kV.
Atomic force microscopy. A minimum of three tails from individual mice per ko
condition were selected, with no less than three tendon extract samples for each
tails. For each tendon extract, seven images per location were taken. Tails were
selected randomly from each mouse to avoid selection bias. Male and female mice
were pooled together. Control, Vps33bﬂ/ﬂ-ERT2 and Vipas39ﬂ/ﬂ-ERT2 mouse tendon
extracts were separated into short (B0.5 cm) lengths, washed in deionized (DI)
water and physisorbed to a glass slide before imaging. AFM was performed on a
Nanowizard (JPK Instruments, Germany) equipped with MSNL-10 cantilevers
(Bruker, UK), mounted on an Olympus IX71 (Olympus, Japan) inverted optical
microscope. Tips with a spring constant rated between k¼ 0.03–0.6 were
employed. Setpoint, integral gain and proportional grain were optimized for each
sample. Both qualitative and quantitative analyses were used. Image processing was
performed on WSxM (Nanotec, Spain) and the proprietary JPK analysis software
(JPK Instruments). 2D FFT was performed on seven height images obtained from
each of the conditions using Gwyddion (Department of Nanometrology, Czech
Metrology Institute, Czech Republic) to characterize the average ﬁbrillar
D-banding. Average D-bandings and deviations (width of the ﬁrst-order FFT arc)
are presented. Line proﬁle analysis was performed on the deﬂection image, pre-
venting baseline curvature from overestimating the banding length and high-
lighting the localized variations in the shape of the ﬁbrillar D-banding was
apparent.
GGT activity measurements. GGT activity measurements on mIMCD3 cell lines
(wild-type, control shRNA, VPS33B shRNA and VIPAR shRNA) media and cell
lysate was measured with a method11 based on the transfer of [3H]glucose from
UDP-[3H]glucose (139 Cimol 1) to galactosylhydroxylysyl residues in a calf skin
gelatin substrate.
After collecting media, cells were ﬁrst washed in PBS and then homogenized in
a Teﬂon-glass homogenizer with 0.1M Glycine, 0.02M Tris-HCl, pH 7.8 and 1%
Igepal CA-630. Homogenates were sonicated three times for 5 s and centrifuged at
14,000g for 15min. Supernatants were collected and used in the assay. Proteins
were ﬁrst precipitated and then hydrolysed overnight in 2N NaOH at 105 C.
The reaction was neutralized and ﬂuorescent FMOC-labelled amino acids were
analysed by Nova-Pak C18-HPLC column (Waters, Milford, MA). For the GGT
activity measurements 1,170 d.p.m. corresponds approximately to 1 ng of LH3
based on the measurements performed using the puriﬁed recombinant LH3
(ref. 11).
Patients’ samples. The research, using skin ﬁbroblast cell lines and urine samples
from patients with ARC syndrome and age-matched control individuals, was
approved by the UCL research ethics committee (REC 13/LO/0168) and all rele-
vant institutional ethics review boards. Informed consent was obtained.
Data availability. Microarray data described in this study has been deposited in
the NCBI GEO database under accession code GSE81376 (http://www.ncbi.nlm.-
nih.gov/geo/query/acc.cgi?acc=GSE81376). The authors declare that all other data
supporting the ﬁndings of this study are available within the article and its
supplementary information ﬁles or are available from the corresponding author
upon request.
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